Browse By: Country ι Category ι Publisher ι Tag
Home  »  In Vitro Diagnostics

In Vitro Diagnostics Market Research Reports

In Vitro diagnostics (IVD) market plays an integral role in detecting or diagnosing infections or diseases under stringent environments such as a laboratory. IVD industry holds a major role in the disease and healthcare management sector. Due to advances in bioinformatics, genomics, microelectronics, and miniaturization, the past few years have changed dramatically for diagnostic laboratory technology. 

t-align: justify;>In vitro diagnostics market is highly reliable when it comes to providing valuable information regarding the physiological and/or pathological state of a patient suffering from a disease. This industry has spread its wings into the clinical and traditional medical engineering segments to blend with industry-specific components derived from computer sciences opening up new niche markets for diagnostic testing. IVD is very essential in the clinical domain to take well-informed medical decisions.  


For the past 15 years, this market has witnessed number of assays growing in an upswing. IVD has contributed to growth in many medical areas, especially in nucleic acid and immunoassays tests. 


A number of patients have succumbed to infectious diseases such as gastrointestinal, sexually transmitted diseases, or respiratory problems. The growing global prevalence of chronic and infectious diseases such as, Chagas, cholera, human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), tuberculosis, measles, Herpes Simplex Virus (HSV), dengue, and malaria will effectively cause an impact on the overall market during the next years. Hence, the global In Vitro Diagnostics Market is growing due to ongoing developments in microbiology, analytical laboratory automation and swift progress in different fields of diagnosis such as molecular diagnosis, point-of-care testing, and immunoassays.  


The global In Vitro market has witnessed dynamic market conditions in terms of rising incidences of chronic diseases, rising per capita income, increasing awareness of health and fitness, demand of efficient and effective health care equipment, as well as major technological advancements. Patients’ self-testing their medical conditions is the most important trend witnessed in the IVD market. A paradigm shift from laboratory testing to point of care testing is one of the major factors responsible for the growth of this industry.


Through Marketresearchreports.biz, you will learn the overall industry nature including the market trends, analysis, and forecasts of the In Vitro Diagnostics market. We provide you with quality-based market research reports that that will decisively give you the edge you need and help you take decisions accordingly.

More

China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis
China is gradually becoming a competitive force and evolving into the world’s fastest growing market for In Vitro Diagnostics (IVD) products. By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013. Immunoassay has the highest market share compared to all other segments of In Vitro Diagnostics. Clinical Chemistry is in the 2nd position, but its market share is declining year on year, however its market is growing year on year. Molecular Diagnostics holds the 3rd position and its market share is also rising year on year. Roche holds the highest market share in China In Vitro Diagnostics market.  This is 3rd edition report on In Vitro Diagnostics sector by Renub Research. Report titled “China In Vitro Diagnostics
Published Date: Dec 2014
Published By: Renub Research

Price: $1400
Non-Invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi and VisibiliT) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2014 - 2020
Non-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X), and also for fetal sex determination. Until recently, amniocentesis, chorionic villus sampling (CVS), maternal serum screening and nuchal translucency (NT) scan were the primary diagnostic and screening methods for chromosomal abnormalities. Advent of non-invasive prenatal test is poised to eliminate disadvantages associated with these methods, such as low rate of accuracy with maternal serum screening and NT scan, and risk of miscarriage with invasive amniocentesis and CVS procedures. This report on non-invasive prenatal testin
Published Date: Nov 2014
Published By: Transparency Market Research

Price: $4795
Molecular Diagnostics Partnering Terms and Agreements
The Molecular Diagnostics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.     This report provides details of the latest molecular diagnostics agreements announced in the healthcare sectors.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - co
Published Date: Oct 2014
Published By: Current Partnering

Price: $1995
China Diagnostic Reagent Industry Report, 2013-2016
With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic reagent industry has been developing quickly, especially in vitro diagnostic reagents occupy over 90%. In 2013, Chinese in vitro diagnostics market size reached RMB22.98 billion, of which RMB16.61 billion came from in vitro diagnostic reagents.    Chinese in vitro diagnostic reagent market consists of biochemical diagnostic reagents, immunodiagnostic reagents and molecular diagnostic reagents. Among them, the immune reagents and biochemical reagents account for a relatively higher combined proportion, such as around 65% in 2013. Currently, about 40%-50% share of the Chinese in vit
Published Date: Jul 2014
Published By: Research In China

Price: $2400
Global Molecular Diagnostics Market Report: 2014 Edition
Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological sciences, in particular, have brought forth advancements that rendered the possibility of deploying certain tests that are performed on patient samples, including blood and tissues, in order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Essentially, In-vitro Diagnostics (IVD) have earned the title of ‘silent champion’ of the healthcare industry since this segment influences more than half of the decision-making in the overall healthcare industry.   Under this umbrella, the fastest growing segment, i.e. molecular diagnostics, involves performing analysis at the molecular level,
Published Date: Jul 2014
Published By: Koncept Analytics

Price: $800
Alere Inc. (ALR) - Product Pipeline Analysis, 2014 Update
Alere Inc. (Alere), (formerly Inverness Medical Innovations, Inc.) is one of the leading providers of point-of-care diagnostics solutions and services. Its solutions and services enable patients to take charge of their own health at home and allow healthcare providers and payors to enhance care, prevent disease advancement and reduce healthcare costs. The company provides near-patient monitoring tools and value-added healthcare services. Its products and services focus on cardiology, women’s health, infectious diseases, diabetes, oncology, and toxicology. Its portfolio portfolio also includes a broad array of health information solutions which increase access to critical health data, provide clinical decision support, and facilitate augmented performance reporting and analysis. I
Published Date: Jun 2014
Published By: GlobalData

Price: $750
Quest Diagnostics Incorporated (DGX) - Product Pipeline Analysis, 2014 Update
Quest Diagnostics Incorporated (Quest Diagnostics) is a medical diagnostics company. It offers diagnostic testing services to patients and physicians through a chain of laboratories and company-owned patient service centers. The company offers comprehensive services such as clinical testing, with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology, and diagnostic products. Quest Diagnostics, along with its subsidiaries and branches, operates in India, Ireland, Mexico, Sweden, the UK, the US, Singapore, China, South America and Australia. Quest Diagnostics is headquartered in Madison, New Jersey, the US.The company intends to grow through acquisitions. To this end, in August 2014, Quest acquir
Published Date: Jun 2014
Published By: GlobalData

Price: $750
Abbott Diagnostics - Product Pipeline Analysis, 2014 Update
Abbott Diagnostics is a provider of in vitro diagnostic products. It provides a wide range of innovative diagnostic instruments, tests and systems for hospitals, blood banks, commercial laboratories, clinics and alternate-care testing sites. The company\'s products range from automated immunodiagnostic systems and blood analyzers to advanced molecular diagnostics and point-of-care devices. It offers core laboratory diagnostic products, including an array of instruments and tests for the global diagnostic market. Besides, it offers immunoassay and clinical chemistry products such as systems and assays for the measurement of a variety of antibodies, antigens and analytes in the blood and for the diagnosis and monitoring of diseases and therapies. It provides blood-screening instrumentati
Published Date: Jun 2014
Published By: GlobalData

Price: $750
bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2014 Update
bioMerieux S.A. (bioMerieux) undertakes the design, development and manufacture of diagnostic systems and reagents for physicians and biologists. It operates through two business divisions, namely, Clinical Applications and Industrial Applications. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used in diagnosing infectious diseases and provide high medical value results in cancer screening and monitoring and cardiovascular emergencies. Its products also detect microorganisms in food, pharmaceutical and cosmetic products. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy lEtoile, France. The company
Published Date: Jun 2014
Published By: GlobalData

Price: $750
Cepheid (CPHD) - Product Pipeline Analysis, 2014 Update
Cepheid is a molecular diagnostic company. It develops, manufactures and commercializes fully-integrated systems for clinical and non-clinical market tests. The company\'s products for clinical markets include IVD medical devices, CE marked products, and research use only tests in the areas of healthcare associated infections, critical infectious disease, sexual health, womens health, virology, oncology and genetics. Cepheids two major systems include the SmartCycler and GeneXpert. The company also offers GeneXpert modules integrated into the biohazard detection systems using its bacillus anthracis test, and its SmartCycler system along with general use PCR reagents and reaction tubes to the non-clinical market. It operates along with its subsidiaries in France, Sweden, the US, Japan,
Published Date: Jun 2014
Published By: GlobalData

Price: $750
MDxHealth SA (MDXH) - Product Pipeline Analysis, 2014 Update
MdxHealth SA (MdxHealth), formerly OncoMethylome Sciences SA, is a molecular diagnostics company. It develops and commercializes advanced epigenetic assays and service testing for the early detection of cancer and personalized treatment decisions. It offers clinical molecular diagnostics solutions (clinicalMdx solution) and pharmaco molecular diagnostics (pharmacoMDx) solutions. The companys products include ConfirmMDx, which detects absence or presence of prostate cancerPredictMDx, which indicates patient response to therapy. Its product pipeline includes InformMDx for prostate cancerand ConfirmMDx and RecurMDx for bladder cancer. The company\'s tests are based on its proprietary MSP methylation technology that assists physicians in the diagnosis of cancer. It also provides indication
Published Date: Jun 2014
Published By: GlobalData

Price: $750
DiaSorin S.p.A (DIA) - Product Pipeline Analysis, 2014 Update
DiaSorinS.p.A. (DiaSorin) is a medical device company. It undertakes the development and manufacture of reagents pertaining to in-vitro diagnostics and systems that enable automatic diagnostic investigation. The company offers products grouped under two segments, namely, immunodiagnostics, and molecular diagnostics. Its key products offerings include radio immuno assays (RIA), enzyme linked immunosorbent assays (ELISA) and chemiluminescent immuno assays (CLIA) under immunediagnosticssegmentand extraction, amplification, and diagnostic products under molecular diagnostics segment. The company also develops and distributes immune reagent kits for clinical diagnostics and equipment that are to be used in combination with reagents, to facilitate automatic diagnostic investigation. The comp
Published Date: Jun 2014
Published By: GlobalData

Price: $750
Blood Products Markets in China
China\'s demand for Blood Products has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China\'s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Published Date: Jun 2014
Published By: Asia Market Information & Development Company

Price: $4000
Home Testing Products Markets in China
China\'s demand for Home Testing Products has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China\'s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Published Date: May 2014
Published By: Asia Market Information & Development Company

Price: $4000
Hemoglobin A1c Testing Devices Market (End-use - Laboratory and Point-of-Care Testing Devices; Technologies - Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This study covers the market analysis for various technologies and end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders for this report include manufacturers of hemoglobin A1C testing analyzers and research organizations involved in developing new and innovative technologies for hemoglobin A1c testing. The market overview section of this report gives a detailed description about the market dynamics and trends including drivers, restraints and opportunities that influence the current and future scenario of this market. This section also covers market attractiveness analysis and Porter’s five forces analysis to give an understanding about the competitive scenario of global hemoglobin A1C testing devices market.  The global hemoglobin A1c testing devices mar
Published Date: May 2014
Published By: Transparency Market Research

Price: $4795
Global and China Over-the-Counter Diagnostic Products Industry 2014 Market Research Report
The report firstly introduced Over-the-Counter Diagnostic Products basic information included Over-the-Counter Diagnostic Products definition Over-the-Counter Diagnostic Products classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Military Infrared (EO/IR) Systemss industry policy and plan, Over-the-Counter Diagnostic Products product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Military Infrared (EO/IR) Systemss capacity production cost Over-the-Counter Diagnostic Products profit production value gross margin etc details information, at the same time, statistics t
Published Date: Apr 2014
Published By: QYResearch

Price: $2200
Global and China Flow Cytometers Industry 2014 Market Research Report
The report firstly introduced Flow Cytometers basic information included Flow Cytometers definition Flow Cytometers classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Military Infrared (EO/IR) Systemss industry policy and plan, Flow Cytometers product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Military Infrared (EO/IR) Systemss capacity production cost Flow Cytometers profit production value gross margin etc details information, at the same time, statistics these manufacturers Flow Cytometers products customers application capacity market position company contac
Published Date: Apr 2014
Published By: QYResearch

Price: $2200
mHealth Monitoring And Diagnostic Medical Devices Market (Focus On Medical Devices With In-Built Plug-Ins For Connectivity With Devices Like Smartphones And Tablets) Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
mHealth is an abbreviation for mobile health, a term used for the practice of medicine and public health supported by mobile devices. The term is most commonly used in reference to using mobile communication devices such as mobile phones, tablets, computers and PDAs for health services and information. This report studies the current scenario as well as the future market potential for mHealth monitoring and diagnostic devices (focus on medical devices with in-built plug-ins for connectivity with devices like smartphones and tablets) globally. The mHealth monitoring and diagnostic devices market has been segmented into seven major product types, namely, glucose monitors, blood pressure monitors, pulse oximeters, cardiac monitors, sleep apnea monitors, multi-parameter monitoring devices and
Published Date: Apr 2014
Published By: Transparency Market Research

Price: $4795
Disposable Gloves (Natural Rubber, Vinyl, Nitrile and Others) Market for Medical and Non-Medical (Food, Cleanroom, Industrial and Other) Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
The global market for disposable gloves is primarily driven by the growing healthcare industry and increasing awareness of hygiene among patients as well as healthcare providers. Disposable gloves have served the medical sector effectively in terms of safety, hygiene and cost-effectiveness. This study analyzes, estimates, and forecasts the global disposable gloves market from the demand perspective, based on volume (million pieces) and revenue (USD million) from 2013 to 2019. The report also analyzes several driving and restraining factors of the market along with their impact over the forecast period. The report provides a detailed view of the disposable gloves market by analyzing the key segments: product and applications. The report segments the market into key products such a
Published Date: Apr 2014
Published By: Transparency Market Research

Price: $4795
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide
Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test. Cervical cancer test market is dominated by United States in 2013. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervica
Published Date: Apr 2014
Published By: Renub Research

Price: $1490
Global and China Molecular Diagnostics equipment Industry 2014 Market Research Report
The report firstly introduced Molecular Diagnostics equipment basic information included Molecular Diagnostics equipment definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Molecular Diagnostics equipment industry policy and plan, Molecular Diagnostics equipment product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Molecular Diagnostics equipment capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Molecular Diagnostics equipment products customers application capacit
Published Date: Mar 2014
Published By: QYResearch

Price: $2200
Global and China Clinical Chemistry Analyzers Industry 2014 Market Research Report
The report firstly introduced Clinical Chemistry Analyzers basic information included Clinical Chemistry Analyzers definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Clinical Chemistry Analyzers industry policy and plan, Clinical Chemistry Analyzers product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Clinical Chemistry Analyzers capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Clinical Chemistry Analyzers products customers application capacity market position
Published Date: Mar 2014
Published By: QYResearch

Price: $2200
Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low Density Multiplexed Assays & Next-Generation Sequencing; Applications: Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR bead-based and microplate assays and next-generation sequencing. Further this market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer’s disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics m
Published Date: Mar 2014
Published By: Transparency Market Research

Price: $4795
Global and China General Assay & Diagnostic Apparatuses Industry 2014 Market Research Report
The report firstly introduced General Assay & Diagnostic Apparatuses basic information included General Assay & Diagnostic Apparatuses definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, General Assay & Diagnostic Apparatuses industry policy and plan, General Assay & Diagnostic Apparatuses product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers General Assay & Diagnostic Apparatuses capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers General Assay &
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China B-type Ultrasonic Diagnostic Apparatus Industry 2014 Market Research Report
The report firstly introduced B-type Ultrasonic Diagnostic Apparatus basic information included B-type Ultrasonic Diagnostic Apparatus definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, B-type Ultrasonic Diagnostic Apparatus industry policy and plan, B-type Ultrasonic Diagnostic Apparatus product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers B-type Ultrasonic Diagnostic Apparatus capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers B-type Ultrasonic Diagnostic Appara
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Investigation Report on China Enoxaparin Sodium Market, 2009 - 2018
Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. It can result in anoxia, the complete deprivation of oxygen and infarction, and even tissue death. Twelve million people worldwide are killed every year by cardiovascular and cerebrovascular diseases such as cerebral thrombosis, cerebral infarction, myocardial infarction, coronary heart disease and arteriosclerosis. It equals to nearly one-fourth of global death toll. Incidence of cardiovascular diseases keeps rising in China. The number of cardiovascular diseases patients in China now is estimated to be 290 million with 2 patients among 10 adults. It is estimated that about 3.5 million people die of cardiovascular diseases every year in China. This number has to
Published Date: Feb 2014
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1800
Global and China Automated Hematology Analyzer Industry 2014 Market Research Report
The report firstly introduced Automated hematology analyzer basic information included Automated hematology analyzer definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Automated hematology analyzer industry policy and plan, Automated hematology analyzer product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Automated hematology analyzer capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Automated hematology analyzer products customers application capacity market pos
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Blood Pressure Monitors Industry 2014 Market Research Report
The report firstly introduced Blood Pressure Monitors basic information included Blood Pressure Monitors definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Blood Pressure Monitors industry policy and plan, Blood Pressure Monitors product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Blood Pressure Monitors capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Blood Pressure Monitors products customers application capacity market position company contact information et
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Blood Circulation Machine Industry 2014 Market Research Report
The report firstly introduced Blood Circulation Machine basic information included Blood Circulation Machine definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Blood Circulation Machine industry policy and plan, Blood Circulation Machine product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Blood Circulation Machine capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Blood Circulation Machine products customers application capacity market position company contact in
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018
Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018 mainly conducts in-depth analysis on the external environment, market operation, import & export of China\'s IVD reagent industry, and also summaries the latest development of key Chinese domestic enterprises in 2013, and finally forecasts the future industrial development. The information can offer investors the decisive reference for their investment in the field. IVD reagent industry is an emerging industry in China, the start is late and the development is relatively backward compares with occidental countries. According to the data provided by IVD Special Committee, there are 300 to 400 IVD reagent manufacturing enterprises in China, of which, 200 enterprises own above designated scale.
Published Date: Feb 2014
Published By: Huidian Research

Price: $2150
Global and China Neuropathology Industry 2013 Market Research Report
The report firstly introduced Neuropathology basic information included Neuropathology definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Neuropathology industry policy and plan, Neuropathology product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Neuropathology capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Neuropathology products customers application capacity market position company contact information etc company related information, then collect all these
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Ultrasonic Diagnostic Apparatus Industry 2014 Market Research Report
The report firstly introduced Ultrasonic diagnostic apparatus basic information included Ultrasonic diagnostic apparatus definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Ultrasonic diagnostic apparatus industry policy and plan, Ultrasonic diagnostic apparatus product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Ultrasonic diagnostic apparatus capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Ultrasonic diagnostic apparatus products customers application capacit
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Diagnostic Ultrasound System Industry 2014 Market Research Report
The report firstly introduced Diagnostic Ultrasound System basic information included Diagnostic Ultrasound System definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Diagnostic Ultrasound System industry policy and plan, Diagnostic Ultrasound System product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Diagnostic Ultrasound System capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Diagnostic Ultrasound System products customers application capacity market position
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Cardiac diagnosis instrument Industry 2014 Market Research Report
The report firstly introduced Cardiac diagnosis instrument basic information included Cardiac diagnosis instrument definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Cardiac diagnosis instrument industry policy and plan, Cardiac diagnosis instrument product specification, manufacturing process, cost structure etc. then statistics Global and China key manufacturers Cardiac diagnosis instrument capacity production cost price profit production value gross margin etc information, and Global and China Cardiac diagnosis instrument capacity production market share supply demand shortage import export consumption etc data statistics, and Cardiac
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Coronary Heart Disease Treatment Instrument Industry 2014 Market Research Report
The report firstly introduced Coronary Heart Disease Treatment Instrument basic information included Coronary Heart Disease Treatment Instrument definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Coronary Heart Disease Treatment Instrument industry policy and plan, Coronary Heart Disease Treatment Instrument product specification, manufacturing process, cost structure etc. then statistics Global and China key manufacturers Coronary Heart Disease Treatment Instrument capacity production cost price profit production value gross margin etc information, and Global and China Coronary Heart Disease Treatment Instrument capacity production mark
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of this market is expected to surge due to various factors such as rise in incidence of hospital acquired infections,
Published Date: Feb 2014
Published By: Transparency Market Research

Price: $4795
Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. 
Published Date: Feb 2014
Published By: Transparency Market Research

Price: $4795
MediPoint: Diagnostic Ultrasound Imaging - US Analysis and Market Forecasts
An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic ultrasound imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of the diagnostic ultrasound imaging market in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the some of the Asia-Pacific (APAC) regions (Japan, China, and India), and identifies the unmet needs in this ultrasound systems market. This report also discusses physician attitudes towards current diagnostic ultrasound techniques, and the future of diagnostic ultrasound imaging in the face of rapid technological advancements. As with other developed countries, t
Published Date: Jan 2014
Published By: GlobalData

Price: $4450
Global In Vitro Diagnostics (IVD) Market Report: 2013 Edition
The process of performing a diagnostic test outside of a living organism in an artificial environment, usually a laboratory, is called in-vitro diagnostic (IVD). IVD is considered as an essential part of today’s healthcare. The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products. IVD is widely used for diagnosis, monitoring of prescribed treatments and assessment of medical intervention, apart from others thereby contributing to availability of medical information regarding a patient. Further, IVD allows earlier and more targeted treatment which in turn leads to reduced hospital stays and convalescences resulting in a healthier population and economic growth in the long run. A consistent increase has been observed in the
Published Date: Jan 2014
Published By: Koncept Analytics

Price: $800
Diagnostic Substances (Global) - Industry Report
Plimsoll Publishing’s Diagnostic Substances (Global) Analysis provides a detailed overview of the Diagnostic Substances (Global) market and delivers a comprehensive individual analysis on the top 60 companies, including ROCHE DIAGNOSTICS GMBH, BERLIN-CHEMIE/MENARINI PHARMA GMBH and ABBOTT ARZNEIMITTEL GMBH.  This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Diagnostic  Substances (Global) analysis is ideal for anyone wanting to: See the market leaders Identify companies heading for failure Seek out the most attractive acquisition Analyse industry trends Benchmark their own financial performance Using Plimsoll’s exclusive methodology, a quick glance of this Diagnosti
Published Date: Jan 2014
Published By: Plimsoll Publishing Ltd.

Price: $1425
MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts
GlobalData has released its medical devices report, “MediPoint: Drug-Eluting Balloons EU Analysis and Market Forecasts”. The report provides in-depth insight into the use of DEB in the European Union (EU) for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occlusions, acute myocardial infarction and lesions in diabetics. The DEB market in the five major EU countries including France, Germany, Italy, Spain and the UK was assessed to identify and determine whether the current unmet needs are addressed, understand the challenges of DEB angioplasty and evaluate the current and future adoption of DEB for select coronary and per
Published Date: Sep 2013
Published By: GlobalData

Price: $4450
Global and China Diagnostic Reagent 2013 Industry Report
The report firstly introduceds diagnostic reagent basic information included definition classification market demand; market demand trends, international market analysis, China domestic market analysis, Diagnostic Reagent product specification etc. then statistics China key manufacturers Diagnostic Reagent market share percentage and market sales etc details information, at the same time, statistics the biochemical diagnoatics, immune dianostics, molecular diagnostics products market sales and market share etc information, then collect all these manufacturers data and listed China Diagnostic Reagent market share and market sales etc data statistics, and then introduced China Diagnostic Reagent 2009-2017 biochemical diagnoatics, immune dianostics, molecular diagnostics products market sales
Published Date: Sep 2013
Published By: QYResearch

Price: $2400
MediPoint: In-Vitro Colorectal Cancer Screening Tests - EU Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment.
Published Date: Aug 2013
Published By: GlobalData

Price: $4450
MediPoint: In-Vitro Colorectal Cancer Screening Tests - US Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment.
Published Date: Aug 2013
Published By: GlobalData

Price: $4450
MediPoint: In-Vitro Colorectal Cancer Screening Tests - APAC Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment.
Published Date: Aug 2013
Published By: GlobalData

Price: $4450
MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players
GlobalData has released its medical device report, MediPoint: In-Vitro Colorectal Cancer Screening Tests Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the steadily growing In-Vitro Colorectal Cancer Screening Tests Market. Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorecta
Published Date: Aug 2013
Published By: GlobalData

Price: $3500
MediPoint: In-Vitro Colorectal Cancer Screening Tests - South America Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment.
Published Date: Aug 2013
Published By: GlobalData

Price: $4450
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2012- 2016
TechNavio\'s analysts forecast the Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 16.37 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high prevalence of sleep apnea. The Global Sleep Apnea Diagnostic and Therapeutic Devices market has also been witnessing an increase in the adoption of home diagnostic devices. However, the lack of patient compliance could pose a challenge to the growth of this market. TechNavio\'s report, the Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2012- 2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas and the EMEA and APAC regions; it also covers the Global Sleep Apnea
Published Date: Aug 2013
Published By: Technavio

Price: $2000
Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year. The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019). The report also contains a section on market ov
Published Date: Aug 2013
Published By: Transparency Market Research

Price: $4595
MediPoint: In-Vitro Colorectal Cancer Screening Tests - Global Analysis and Market Forecasts
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. CRC screening can improve survival rates, and reduce the overall cost of patient treatment. Ques
Published Date: Aug 2013
Published By: GlobalData

Price: $6495
Research on China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2013-2017
Research on China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2013-2017” mainly conducts in-depth analysis on the external environment, market operation, import &export, as well as other aspects of China’s IVD reagent industry, and also summaries the latest development state in 2012 of key domestic enterprises, and finally forecasts the future industrial development. The information can provide investors with decision-making reference. IVD reagent industry is an emerging industry in China, the start is late and the development is relatively backward compares with occidental countries. According to the data provided by IVD Special Committee, there are 300 to 400 IVD reagent manufacturing enterprises in China, of which, 200 enterprises own above designated scale;
Published Date: Aug 2013
Published By: Huidian Research

Price: $1700
Research Report on Global and China In-vitro Diagnostic Reagent Industry, 2013-2017
In Chinese market, there are mainly three categories of invitro diagnostic reagents, biochemical diagnostic reagents, immune diagnostic reagents and molecular diagnostic reagents, accounting for about 65% of invitro diagnostic reagent market in total in 2012.  Global invitro diagnostics market is mature and the concentration rate is high. The 8 major enterprises account for over 70% market share. In 2011, the market scale of global invitro diagnostics reached USD 46 billion, among which developed countries accounted for over 80%. Currently, emerging economic entities occupy low proportions, while their growth rates are far ahead of that of mature markets.  In China, barriers to entry of this industry are not high and the concentration rate is low. The majority of enterprise
Published Date: Aug 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $2200
In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018
In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 – 2018, keeping 2011 as the base year. The in vitro diagnostics market is segmented into two major types namely market by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report. The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The g
Published Date: Aug 2013
Published By: Transparency Market Research

Price: $4595
Global In Vitro Diagnostics Market - Customization
Global In Vitro Diagnostics Market - Customization
Published Date: Jul 2013
Published By: Transparency Market Research

Price: $1750
Global IVD Products and Test Market-Strategic Volume and Pricing Analysis 2012-2016
TechNavio\'s analysts forecast the Global In Vitro Diagnostics (IVD) Products and Test market to grow at a CAGR of 4.33 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant growth of the IVD market in emerging countries. The market has also been witnessing a significant increase in the number of acquisitions of small and medium companies. However, the emergence of counterfeit or duplicate IVD products could pose a challenge to the growth of this market. TechNavio\'s report, the Global IVD Products and Test Market - Strategic Volume and Pricing Analysis 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions
Published Date: Jul 2013
Published By: Technavio

Price: $4000
Global Molecular Diagnostics Market Report: 2013 Edition
Human race has been persistently involved in a never ending pursuit for discovery and innovation in every field with a special inclination towards medical sciences. The perseverant efforts have triggered swift evolution in the realm of diagnostic tools and techniques. In-vitro diagnostic (IVD) tests are deployed for examining specimens including blood and tissues extracted from human body chiefly in order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Under the IVD market falls the ‘Molecular Diagnostics’ sector which involves performing analysis at the molecular level, and thereby measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states
Published Date: Jul 2013
Published By: Koncept Analytics

Price: $800
Global Genetic Testing Market 2012-2016
TechNavio\'s analysts forecast the Global Genetic Testing market to grow at a CAGR of 9.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing global aging population. The Global Genetic Testing market has also been witnessing the increasing availability of Direct to Consumer (DTC) tests. However, the absence of credible standard procedures could pose a challenge to the growth of this market. TechNavio\'s report, the Global Genetic Testing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global Genetic Testing market landscape and its growth prospects in the coming years. Th
Published Date: Jul 2013
Published By: Technavio

Price: $2500
Avibactam - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Avibactam Avibactam indications: Treatment of Gram-negative bacterial infections including complicated intra-abdominal infections and complicated urinary tract infections in combination with Ceftazidime or Ceftaroline Avibactam innovator:  Examples of information found in this online report include: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions
Published Date: Jun 2013
Published By: GenericsWeb

Price: $1200
Avibactam - Comprehensive patent search
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.  Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information. Pipeline Developer features:  Comprehensive patent searching, covering the world\'s key territories (see \'s
Published Date: Jun 2013
Published By: GenericsWeb

Price: $7200
Point of Care Diagnostics Market: Products, Players and Outlook
Vol 1: Cardiology Diagnostics | Vol 2: Hospital-based Diagnostics | Vol 3: Physician-based Diagnostics | Vol 4: Infectious Diseases Diagnostics A complete and practical analysis packed with facts, figures, forecasts and product/competitive assessments  Critical analysis and 5-year forecasts of key point-of-care diagnostic technologies, their prospects and the companies driving change and innovation. The In Vitro diagnostics market was worth approximately US$43 billion in 2011 and grew approximately 4% compared with 2010. The Point-of-Care (POC) sector represents 35% of the overall market and was valued at US$15.1 billion in 2011. The products covered in this report include those used by healthcare professionals and self-testers, which accounted for 33% of the POC sector,
Published Date: May 2013
Published By: Espicom

Price: $3615
Cell Culture Market (Media, Sera, Reagents, Serum-Free Media, Albumin, Growth Factors & Cytokines, Instruments, Bioreactors, Roller Bottle Equipment, T-Flasks And Cryostorage Equipment) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
The cell culture market is experiencing impressive growth globally because of the tremendous increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life science industry, the cell culture market has experienced huge growth in terms of scope as well as adoption by end users. The rapid double-digit growth in biotechnology and biopharmaceutical industries is slated to be the major driving force for the growth of the cell culture market in the future. This report analyses the global market for cell culture by the two main types of products- consumables and instruments. Each of these segments has been further divided and analyzed by various product types offered by manufacturers. The market has also been segmented on the basis of end users in
Published Date: May 2013
Published By: Transparency Market Research

Price: $4595
In Vitro Diagnostics Markets in China
China's demand for in vitro diagnostics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.
Published Date: May 2013
Published By: Asia Market Information & Development Company

Price: $2000
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Global Analysis and Market Forecasts
Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro diagnostic cardiac biomarker tests. The ACS diagnostic cardiac biomarker reagents market is dominated by the cardiac troponins, the gold-standard biomarkers for the diagnosis of MI. In the US and Europe, the troponin market has reached saturation, therefore growth for these tests will be driven by increased uptake in the emerging markets of Braz
Published Date: Apr 2013
Published By: GlobalData

Price: $6495
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Current and Future Players
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes Current and Future Players Summary Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro diagnostic cardiac biomarker tests. Emergence of two pipeline biomarker tests, Thermo Scientifics copeptin, and heart-type fatty acid binding protein (H-FABP), will provide further diagnostic options to emergency physicians.  Th
Published Date: Apr 2013
Published By: GlobalData

Price: $3500
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes EU Analysis and Market Forecasts Summary In Europe, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, the emergence of pipeline biomarker tests will change the landscape of ACS in vitro diagnostic testing and is expected to provide enhancements in the early diagnosis of the disease. Acute coronary syndrome (ACS) consists of two major diseases, myocardial infarction (MI) and unstable angina,
Published Date: Apr 2013
Published By: GlobalData

Price: $4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - US Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes US Analysis and Market Forecasts Summary In the US, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, the emergence of pipeline biomarker tests will change the landscape of ACS in vitro diagnostic testing and is expected to provide enhancements in the early diagnosis of the disease. Acute coronary syndrome (ACS) consists of two major diseases, myocardial infarction (MI) and unstable ang
Published Date: Apr 2013
Published By: GlobalData

Price: $4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes APAC Analysis and Market Forecasts Summary The ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, the emergence of pipeline biomarker tests will change the landscape of ACS in vitro diagnostic testing and is expected to provide enhancements in the early diagnosis of the disease. Acute coronary syndrome (ACS) consists of two major diseases, myocardial infarction (MI) and unstable angina, with
Published Date: Apr 2013
Published By: GlobalData

Price: $4450
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - South America Analysis and Market Forecasts
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes South AmericaAnalysis and Market Forecasts Summary This report focuses on the Diagnostic Cardiac Biomarkers market in South America, principally Brazil. The ACS in vitro diagnostics market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme and myoglobin. Furthermore, the emergence of pipeline biomarker tests will change the landscape of ACS in vitro diagnostic testing and is expected to provide enhancements in the early diagnosis of the disease. Also, due to the increasing number of cases of ACS in Brazil, GlobalData expects this ma
Published Date: Apr 2013
Published By: GlobalData

Price: $4450
Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis
Global Molecular Diagnostics Market & Future Forecast to 2017 Overview The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness significant developments in molecular diagnostics such as automation, as well as introduction of a wide range of new products. Molecular Diagnostics involves multiple technologies to identify genetic variations in individual patients. These technologies include PCR, FISH, hybrid capture, sequencing and microarrays. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuellin
Published Date: Apr 2013
Published By: Renub Research

Price: $1400
Global Plasma Market 2012-2016
TechNavio's analysts forecast the Global Plasma market to grow at a CAGR of 10.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Plasma market has also been witnessing the trend of increasing market consolidation. However, stringent regulations could pose a challenge to the growth of this market. TechNavio's report, the Global Plasma Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global plasma market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.Key vendor
Published Date: Mar 2013
Published By: Technavio

Price: $2000
Diagnostic Reagent Markets in China
China's demand for diagnostic reagent has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.
Published Date: Mar 2013
Published By: Asia Market Information & Development Company

Price: $2000
MediPoint: Predictive Breast Cancer Gene Testing - US Analysis and Market Forecasts
MediPoint: Predictive Breast Cancer Gene Testing US Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the market is depe
Published Date: Feb 2013
Published By: GlobalData

Price: $4450
MediPoint: Predictive Breast Cancer Gene Testing - EU Analysis and Market Forecasts
MediPoint: Predictive Breast Cancer Gene Testing EU Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the market is dependen
Published Date: Feb 2013
Published By: GlobalData

Price: $4450
MediPoint: Predictive Breast Cancer Gene Testing - APAC Analysis and Market Forecasts
MediPoint: Predictive Breast Cancer Gene Testing APAC Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the market is de
Published Date: Feb 2013
Published By: GlobalData

Price: $4450
MediPoint: Predictive Breast Cancer Gene Testing - South America Analysis and Market Forecasts
MediPoint: Predictive Breast Cancer Gene Testing South America Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the mar
Published Date: Feb 2013
Published By: GlobalData

Price: $4450
China Thrombin Industry 2013 Market Research Report
2013 Market Research Report on China Thrombin Industry was professional and depth research report on China Thrombin industry.  The report firstly introduced Thrombin basic information included Thrombin definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Thrombin industry policy and plan, Thrombin product specification, manufacturing process, product cost structure etc. then statistics China key manufacturers Thrombin capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Thrombin products customers application capacity market posit
Published Date: Feb 2013
Published By: QYResearch

Price: $2000
MediPoint: Predictive Breast Cancer Gene Testing - Current and Future Players
MediPoint: Predictive Breast Cancer Gene Testing Current and Future Players Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Improved surveillance in developing countries has allowed the identification of more women with breast cancer in these regions. Early diagnosis of breast cancer is essential for a good prognosis, making diagnosis a cornerstone of breast cancer control. Predictive gene testing can identify women who are at heightened risk of developing breast cancer due to hereditary gene factors. This report focuses on the predictive breast cancer gene testing markets in the US and
Published Date: Feb 2013
Published By: GlobalData

Price: $3500
Alere Inc. Market Share Analysis
Alere Inc. Market Share Analysis Summary GlobalDatas new report, Alere Inc. Market Share Analysis provides in-depth information on Alere Inc.s market position in the different medical equipment markets it operates in. The report provides Alere Inc. market share information in three key market categories Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from pr
Published Date: Feb 2013
Published By: GlobalData

Price: $1000
PerkinElmer, Inc. Market Share Analysis
PerkinElmer, Inc. Market Share Analysis Summary GlobalDatas new report, PerkinElmer, Inc. Market Share Analysis provides in-depth information on PerkinElmer, Inc.s market position in the different medical equipment markets it operates in. The report provides PerkinElmer, Inc. market share information in two key market categories Immuno Chemistry and Infectious Immunology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced fro
Published Date: Feb 2013
Published By: GlobalData

Price: $1000
Qiagen N.V Market Share Analysis
Qiagen N.V Market Share Analysis Summary GlobalDatas new report, Qiagen N.V. Market Share Analysis provides in-depth information on Qiagen N.V.s market position in the different medical equipment markets it operates in. The report provides Qiagen N.V. market share information in two key market categories Infectious Immunology and Genetic Testing. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, p
Published Date: Feb 2013
Published By: GlobalData

Price: $1000
Thermo Fisher Scientific, Inc. Market Share Analysis
Thermo Fisher Scientific, Inc. Market Share Analysis Summary GlobalDatas new report, Thermo Fisher Scientific, Inc. Market Share Analysis provides in-depth information on Thermo Fisher Scientific, Inc.s market position in the different medical equipment markets it operates in. The report provides Thermo Fisher Scientific, Inc. market share information in five key market categories Infectious Immunology, Microbiology Culture, Immuno Chemistry, Clinical Chemistry and Histology And Cytology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and s
Published Date: Feb 2013
Published By: GlobalData

Price: $1000
MediPoint: Predictive Breast Cancer Gene Testing - Global Analysis and Market Forecasts
Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics position in the market is dependent on it being the leading provider of the most common breast cancer mutations. By the end of
Published Date: Feb 2013
Published By: GlobalData

Price: $6495
Span Diagnostics Ltd. Market Share Analysis
Span Diagnostics Ltd. Market Share Analysis Summary GlobalDatas new report, Span Diagnostics Ltd. Market Share Analysis provides in-depth information on Span Diagnostics Ltd.s market position in the different medical equipment markets it operates in. The report provides Span Diagnostics Ltd. market share information in five key market categories Clinical Chemistry, Haematology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key deve
Published Date: Feb 2013
Published By: GlobalData

Price: $1000
Cepheid Market Share Analysis
Cepheid Market Share Analysis Summary GlobalDatas new report, Cepheid Market Share Analysis provides in-depth information on Cepheids market position in the different medical equipment markets it operates in. The report provides Cepheid market share information in two key market categories Genetic Testing and Infectious Immunology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and seco
Published Date: Feb 2013
Published By: GlobalData

Price: $1000
OraSure Technologies, Inc. Market Share Analysis
OraSure Technologies, Inc. Market Share Analysis Summary GlobalDatas new report, OraSure Technologies, Inc. Market Share Analysis provides in-depth information on OraSure Technologies, Inc.s market position in the different medical equipment markets it operates in. The report provides OraSure Technologies, Inc. market share information in one key market category Infectious Immunology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information so
Published Date: Feb 2013
Published By: GlobalData

Price: $1000
HORIBA, Ltd. Market Share Analysis
HORIBA, Ltd. Market Share Analysis Summary GlobalDatas new report, HORIBA, Ltd. Market Share Analysis provides in-depth information on Horiba, Ltd.s market position in the different medical equipment markets it operates in. The report provides Horiba, Ltd. market share information in one key market category Haematology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and secondary resear
Published Date: Feb 2013
Published By: GlobalData

Price: $1000
Grifols, S.A. Market Share Analysis
Grifols, S.A. Market Share Analysis Summary GlobalDatas new report, Grifols, S.A. Market Share Analysis provides in-depth information on Grifols, S.A.s market position in the haematology market. The report also provides data and information on the overall competitive landscape within the haematology market. The report is supplemented with global corporate-level profile with information on the companys business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts. Scope Global company shares (in Revenues) information for the
Published Date: Jan 2013
Published By: GlobalData

Price: $1000
Point of Care Testing Market and Forecast to 2016: Global Analysis
Point of Care Testing Market Overview The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.  Blood glucose test controls a lion’s market share
Published Date: Jan 2013
Published By: Renub Research

Price: $1275
Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalDatas new report, Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 provides key market data on the Infectious Immunology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within five market categories Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology. The report also provides company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on
Published Date: Jan 2013
Published By: GlobalData

Price: $2500
Asia-Pacific In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
Asia-Pacific In Vitro Diagnostics Market Outlook to 2018Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture Summary GlobalDatas new report, Asia-Pacific In Vitro Diagnostics Market Outlook to 2018Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the Asia-Pacific In Vitro Diagnostics market Australia, China, India and Japan. The report provides value (USD million) data for all the market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and dis
Published Date: Jan 2013
Published By: GlobalData

Price: $3500
New Zealand In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
New Zealand In Vitro Diagnostics Market Outlook to 2018 Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture Summary GlobalDatas new report, New Zealand In Vitro Diagnostics Market Outlook to 2018 Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the New Zealand In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within market categories Clinical Chemistry, Haematology, Immuno Chemistry, Histology And Cytology, Infectious Immunology, Microbiology Culture and Genetic Testing. The report also provides company shares and distributi
Published Date: Jan 2013
Published By: GlobalData

Price: $2500
United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
Global Markets Directs new report, United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the United Arab Emirates In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.  The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.This report is built u
Published Date: Jan 2013
Published By: Global Markets Direct

Price: $2500
Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
Global Markets Directs new report, Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Chile In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.  The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.This report is built using data and information sour
Published Date: Jan 2013
Published By: Global Markets Direct

Price: $2500
Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
Global Markets Directs new report, Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Norway In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.  The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.This report is built using data and information so
Published Date: Jan 2013
Published By: Global Markets Direct

Price: $2500
Ireland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
Global Markets Directs new report, Ireland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Ireland In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.  The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information
Published Date: Dec 2012
Published By: Global Markets Direct

Price: $2500
Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
Global Markets Directs new report, Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Greece In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.  The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information s
Published Date: Dec 2012
Published By: Global Markets Direct

Price: $2500
Hungary In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
Global Markets Directs new report, Hungary In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Hungary In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.  The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information
Published Date: Dec 2012
Published By: Global Markets Direct

Price: $2500
Poland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
Global Markets Directs new report, Poland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Poland In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.  The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information s
Published Date: Dec 2012
Published By: Global Markets Direct

Price: $2500
Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
Global Markets Directs new report, Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Portugal In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.  The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and informati
Published Date: Dec 2012
Published By: Global Markets Direct

Price: $2500
Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
Global Markets Directs new report, Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Switzerland In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.  The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and inf
Published Date: Dec 2012
Published By: Global Markets Direct

Price: $2500